This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial...
New FDA guidance on psychedelics changes little for researchers but could open minds and funding sources. The post New FDA Guidance on Psychedelics Could...
Which psychedelics will be next to be FDA approved? We take a closer look. The post Legal Psychedelics: Which Compounds Will Be Approved Next? appeared...
Source: Streetwise Reports 07/12/2023 A non-brokered private placement for a company zeroing in on addiction treatments is being oversubscribed...
Psyence stretched its fiscal runway and paid off all the debt on its balance sheet. The post Psyence Prepares for Phase 2b Clinical Trial in Australia...
We’re inside the headquarters of Outpace Bio in Seattle. Senior scientist Bobby Langan shows a video of one of his favorite deep-learning tools, used...
We’re inside the headquarters of Outpace Bio in Seattle. Senior scientist Bobby Langan shows a video of one of his favorite deep-learning tools, used...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical–stage natural psychedelic drug development company, today announced that it will...
-Cybin Inc. (NEO:CYBN / NYSE American:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new...
A statewide proposal, if passed, will allocate settlement funds from lawsuits against corporations involved in the opioid crisis towards research into...